[go: up one dir, main page]

UA48937C2 - Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить - Google Patents

Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить

Info

Publication number
UA48937C2
UA48937C2 UA95094318A UA95094318A UA48937C2 UA 48937 C2 UA48937 C2 UA 48937C2 UA 95094318 A UA95094318 A UA 95094318A UA 95094318 A UA95094318 A UA 95094318A UA 48937 C2 UA48937 C2 UA 48937C2
Authority
UA
Ukraine
Prior art keywords
synthesis
substances
pharmaceutical composition
optionally substituted
substituted
Prior art date
Application number
UA95094318A
Other languages
English (en)
Russian (ru)
Inventor
Андре Клосснер
Франсуа Губе
Жан-Жорж Тьотш
Original Assignee
Хьохст Маріон Руссель
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хьохст Маріон Руссель, Хехст Марион Руссель filed Critical Хьохст Маріон Руссель
Publication of UA48937C2 publication Critical patent/UA48937C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Предмет винаходу становлять, зокрема, сполуки формули (I) , (I) де • являє собою арильний радикал, який може бути заміщено на ціано-, нітро- радикали, атом галогену, трифторметильним, карбоксильним вільним, перетвореним на складний ефір або сіль, алкоксильним, алкілтіонільним радикалом; • являє собою атом кисню чи сірки, а - атом водню, алкільний, алкенільний, алкінільний, арильний або арилалкильний радикал, с можливістю заміщення; • являє собою атом кисню чи сірки або радикал ; • являє собою насичений гетероцикл, який включає , або , с можливістю заміщення. Описані сполуки мають антиандрогенну активність і можуть застосовуватись як лікарські засоби. Наведено також спосіб отримання таких імідазолідинів. Описано фармацевтичну комозицію на основі цих сполук.
UA95094318A 1994-09-29 1995-09-27 Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить UA48937C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411649A FR2725206B1 (fr) 1994-09-29 1994-09-29 Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
UA48937C2 true UA48937C2 (uk) 2002-09-16

Family

ID=9467411

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95094318A UA48937C2 (uk) 1994-09-29 1995-09-27 Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить

Country Status (19)

Country Link
US (3) US5646172A (uk)
EP (1) EP0704448B1 (uk)
JP (1) JPH0899977A (uk)
CN (1) CN1055471C (uk)
AT (1) ATE210134T1 (uk)
AU (1) AU707569B2 (uk)
BR (1) BR9504205A (uk)
CA (1) CA2159425A1 (uk)
DE (1) DE69524344T2 (uk)
DK (1) DK0704448T3 (uk)
ES (1) ES2169112T3 (uk)
FI (1) FI111259B (uk)
FR (1) FR2725206B1 (uk)
HU (1) HU222564B1 (uk)
IL (1) IL114939A (uk)
PT (1) PT704448E (uk)
RU (1) RU2170231C2 (uk)
UA (1) UA48937C2 (uk)
ZA (1) ZA957568B (uk)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741342B1 (fr) * 1995-11-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
FR2742749B1 (fr) * 1995-12-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
DE19632126A1 (de) * 1996-08-09 1998-02-12 Bayer Ag Phenylsubstituierte cyclische Ketoenole
US20020142993A1 (en) * 2000-10-12 2002-10-03 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of bicyclic compounds
PT1385515E (pt) * 2001-04-18 2008-09-15 Euro Celtique Sa Compostos de espiropirazole
RU2243227C1 (ru) * 2003-07-25 2004-12-27 Институт проблем химической физики РАН (dl)-1-гидрокси-3,7,7,9,9-пентаметил-1,4,8-триазаспиро [4,5] декан-2-он и способ его получения
CA2579609A1 (en) * 2003-09-10 2005-03-17 Virochem Pharma Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
JP2007514442A (ja) * 2003-12-19 2007-06-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 前立腺癌治療を評価するための方法および物質
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
KR20240148945A (ko) 2005-05-13 2024-10-11 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴히단토인 화합물
AU2006270084B2 (en) * 2005-07-18 2011-08-25 Merck Sharp & Dohme Corp. Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
CN101454002B (zh) * 2006-03-27 2011-06-08 加利福尼亚大学董事会 用于治疗前列腺癌和与雄激素受体相关的疾病的雄激素受体调节剂
KR20160027254A (ko) 2006-03-29 2016-03-09 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
GB0610765D0 (en) * 2006-05-31 2006-07-12 Proskelia Sas Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
US8168667B2 (en) 2006-05-31 2012-05-01 Galapagos Nv Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
CA2662776A1 (en) * 2006-09-07 2008-03-13 Merck And Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
JP5535925B2 (ja) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
IN2012DN02580A (uk) 2009-09-04 2015-08-28 Univ Vanderbilt
CA2772579C (en) * 2009-09-10 2015-12-08 Youzhi Tong Thioimidazolidinone androgen receptor antagonists and uses thereof
CA2787083C (en) 2010-02-16 2018-05-22 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
RU2434851C1 (ru) * 2010-07-22 2011-11-27 Александр Васильевич Иващенко Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
JP5833681B2 (ja) * 2011-03-10 2015-12-16 蘇州開拓薬業有限公司Ｓｕｚｈｏｕｋｉｎｔｏｒ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． アンドロゲン受容体アンタゴニストおよびその使用
IL312316A (en) 2012-09-26 2024-06-01 Aragon Pharmaceuticals Inc Antiandrogens for the treatment of castration-resistant prostate cancer without metastases
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
US10011874B2 (en) 2013-02-25 2018-07-03 Novartis Ag Androgen receptor mutation
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US20190209469A1 (en) 2016-08-20 2019-07-11 Ftf Pharma Private Limited Pharmaceutical composition comprising an androgen receptor inhibitor
CA3079135A1 (en) 2017-10-16 2019-04-25 Arturo Molina Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS421179Y1 (uk) * 1964-03-13 1967-01-24
JPS4623738Y1 (uk) * 1968-05-29 1971-08-16
DE2126532A1 (de) * 1971-05-28 1972-12-07 Merck Patent Gmbh, 6100 Darmstadt Neue Derivate der 6-Aminopenicillansäure und Verfahren zu ihrer Herstellung
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4320135A (en) * 1980-05-19 1982-03-16 Sandoz, Inc. Inhibiting growth hormone secretion with 5,5-substituted hydantoin derivatives
DE3382406D1 (de) * 1982-04-08 1991-10-17 Shell Int Research Neue hydantoine, ihre herstellung und verwendung.
US5221675A (en) * 1989-12-15 1993-06-22 Abbott Laboratories Aza-spirocyclic compounds that enhance cholinergic neurotransmission
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
HUT72748A (en) 1996-05-28
PT704448E (pt) 2002-05-31
DE69524344D1 (de) 2002-01-17
ES2169112T3 (es) 2002-07-01
US5705654A (en) 1998-01-06
IL114939A0 (en) 1995-12-08
EP0704448B1 (fr) 2001-12-05
US5646172A (en) 1997-07-08
CA2159425A1 (fr) 1996-03-30
FR2725206B1 (fr) 1996-12-06
BR9504205A (pt) 1996-08-06
ZA957568B (en) 1996-09-09
AU3292195A (en) 1996-04-18
FI111259B (fi) 2003-06-30
JPH0899977A (ja) 1996-04-16
CN1055471C (zh) 2000-08-16
US5958936A (en) 1999-09-28
IL114939A (en) 2005-11-20
RU2170231C2 (ru) 2001-07-10
FI954612L (fi) 1996-03-30
ATE210134T1 (de) 2001-12-15
DE69524344T2 (de) 2002-08-22
EP0704448A1 (fr) 1996-04-03
HU222564B1 (hu) 2003-08-28
HU9502841D0 (en) 1995-11-28
AU707569B2 (en) 1999-07-15
FR2725206A1 (fr) 1996-04-05
CN1127753A (zh) 1996-07-31
DK0704448T3 (da) 2002-03-25
FI954612A0 (fi) 1995-09-28

Similar Documents

Publication Publication Date Title
UA48937C2 (uk) Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ZA857523B (en) Pharmaceutical compositions containing diazepines and having a paf-antagonistic activity
NO304070B1 (no) Benzimidazolon-derivater, farmasöytiske preparater inneholdende dem og anvendelse av dem
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
BG103207A (en) Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation
JPS5665869A (en) Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
HUT36127A (en) Process for preparing new pyrrolo-benzoxazepines
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
ES8607263A1 (es) Un procedimiento de preparacion de compuestos heterociclicos
ATE41146T1 (de) Irreversible dopamin-b-hydroxylase-inhibitoren.
HU9800970D0 (en) Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
PH24762A (en) 1,6-naphthyridine derivatives, pharmaceutical compositions and method of use
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
ATE91489T1 (de) Heterocyclische propenamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NO994764L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende disse
KR880012587A (ko) 치환된 퀴녹살릴-이미다졸리딘-2,4-디온, 이의 제조 방법, 및 약제 및 약제학적 제제로서의 이의 용도
ES8608488A1 (es) Un metodo para preparar nuevas 1-aminoalquil-amino-4-arilo- xipiperidinas sustituidas
IL116382A0 (en) Trisubstituted t hoxanthines and pharmaceutical compositions containing the same
HUT53638A (en) Process for producing 15-amino-substituted 20,21-dinoreburnamenie derivatives and pharmaceutical compositions containing them
ES8304989A1 (es) Mejoras introducidas en un procedimiento para la preparacion hidroximidatos y tiolhidroximidatos heterobiciclicos y de- rivados ester carbomatos de los mismos.